Intention-to-Treat Analysis of 68Ga-PSMA and 11C-Choline PET/CT Versus CT for Prostate Cancer Recurrence After Surgery

Conclusion: 68Ga-PSMA PET/CT is cost-effective in all patients with regard to avoidance of incorrect treatment. It enabled new curative options for patients with previous radiotherapy who are usually treated palliatively. Therefore, 68Ga-PSMA PET/CT staging should become standard for BCR after surgery with or without radiotherapy.

Source: Journal of Nuclear Medicine - September 30, 2019 Category: Nuclear Medicine Authors: Schwenck, J., Olthof, S.-C., Pfannenberg, C., Reischl, G., Wegener, D., Marzec, J., Bedke, J., Stenzl, A., Nikolaou, K., la Fougere, C., Zips, D., Muller, A.-C. Tags: Clinical Source Type: research